Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies

Taispeáin leaganacha eile (1)

OBJECTIVE:Fatigue is a common and disabling symptom amongst people with multiple sclerosis, however it has not been compared across the central nervous system (CNS) inflammatory diseases associated with aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). We explored the...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Yeo, T, Dos Passos, GR, Muhammed, L, Everett, R, Reeve, S, Messina, S, Probert, F, Leite, MI, Jacqueline Palace
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Wiley 2020

Míreanna comhchosúla

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
de réir: Tianrong Yeo, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
de réir: Jurynczyk, M, et al.
Foilsithe / Cruthaithe: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
de réir: Jurynczyk, M, et al.
Foilsithe / Cruthaithe: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
de réir: Maciej Jurynczyk, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
de réir: Jurynczyk, M, et al.
Foilsithe / Cruthaithe: (2016)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
de réir: Waters, P, et al.
Foilsithe / Cruthaithe: (2015)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2014)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
de réir: Juryńczyk, M, et al.
Foilsithe / Cruthaithe: (2016)

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
de réir: Messina, S, et al.
Foilsithe / Cruthaithe: (2021)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
de réir: Sato, D, et al.
Foilsithe / Cruthaithe: (2014)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
de réir: Kezuka, T, et al.
Foilsithe / Cruthaithe: (2014)

No strong HLA association with MOG antibody disease in the UK population
de réir: Grant-Peters, M, et al.
Foilsithe / Cruthaithe: (2021)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
de réir: Jae-Won Hyun, et al.
Foilsithe / Cruthaithe: (2020-06-01)

International multicenter examination of MOG antibody assays
de réir: Reindl, M, et al.
Foilsithe / Cruthaithe: (2020)

Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder
de réir: Hacohen, Y, et al.
Foilsithe / Cruthaithe: (2018)

No strong HLA association with MOG antibody disease in the UK population
de réir: Melissa Grant‐Peters, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
de réir: V. E. Avdeeva, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Disease course and disability outcomes in MOG-antibody disease in the UK
de réir: Jurynczyk, M, et al.
Foilsithe / Cruthaithe: (2017)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
de réir: Chuan-bin Sun
Foilsithe / Cruthaithe: (2023-11-01)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
de réir: Jurynczyk, M, et al.
Foilsithe / Cruthaithe: (2017)

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
de réir: Lin Zhou, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Differences in Neuropathic Pain and Radiological Features Between AQP4-ON, MOG-ON, and IDON
de réir: Hao Kang, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
de réir: Elisabeth Maillart, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
de réir: Luca Bollo, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Case report: Satralizumab as an adjunctive therapy for AQP-4 antibody and MOG antibody dual-negative optic neuritis in a third-trimester pregnancy case
de réir: Chuanbin Sun, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
de réir: Xuelian Chen, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
de réir: Xuelian Chen, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
de réir: Bing-Yan Ren, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
de réir: Sotaro Mori, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
de réir: Chenyang Gao, et al.
Foilsithe / Cruthaithe: (2021-06-01)

We need to talk about MOG
de réir: Waters, P, et al.
Foilsithe / Cruthaithe: (2020)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
de réir: Pace, S, et al.
Foilsithe / Cruthaithe: (2021)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
de réir: Jarius, S, et al.
Foilsithe / Cruthaithe: (2018)

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
de réir: Whittam, DH, et al.
Foilsithe / Cruthaithe: (2020)

MOG antibody associated disorder (MOGAD)
de réir: Lilley Kate, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Epilepsy in patients with MOG antibody disease
de réir: Varvara E. Avdeeva, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders
de réir: Elena H. Martinez-Lapiscina, et al.
Foilsithe / Cruthaithe: (2016-09-01)

A rare case of systemic lupus erythematosus‐associated neuromyelitis optica spectrum disorder with cystic lesions and dual seropositivity for anti‐AQP4 and anti‐MOG antibodies
de réir: Omar Al Jassem, et al.
Foilsithe / Cruthaithe: (2024-09-01)

The Role of Peripheral CNS‐Directed Antibodies in Promoting Inflammatory CNS Demyelination
de réir: Silke Kinzel, et al.
Foilsithe / Cruthaithe: (2017-06-01)

Atypical inflammatory demyelinating syndromes of the CNS
de réir: Hardy, T, et al.
Foilsithe / Cruthaithe: (2016)